琥珀酸在肿瘤代谢中不断演变的作用:一项基于18F-FDG的研究
研究探讨琥珀酸是否驱动SDH缺陷肿瘤的高18F-FDG摄取。体外及小动物PET/CT实验显示,瘤内注射琥珀酸显著增加18F-FDG摄取,且琥珀酸以浓度依赖方式增加人脐静脉内皮细胞的18F-FDG摄取。结论认为琥珀酸刺激内皮细胞摄取18F-FDG,部分解释SDH缺陷肿瘤的18F-FDG代谢表型。
要点
- 瘤内注射琥珀酸显著增加小动物PET/CT及放射自显影中24小时的18F-FDG摄取。
- 琥珀酸以浓度依赖方式增加人脐静脉内皮细胞的18F-FDG摄取,体外对癌细胞无此效应。
- 琥珀酸、富马酸和PBS对细胞活力无影响,GLUT1表达在各组间无显著差异。
核心结论
- 本研究显示琥珀酸刺激内皮细胞摄取18F-FDG,部分解释SDH缺陷肿瘤中观察到的18F-FDG代谢表型。
- 尽管本研究是基于18F-FDG的方法,但为更好表征各种肿瘤及其微环境中18F-FDG摄取的决定因素提供了动力,尤其强调肿瘤特异性癌代谢物的作用。
研究设计与样本
- 体外和体内(小动物PET/CT显像及放射自显影)实验,在不同细胞模型中在琥珀酸、富马酸和磷酸盐缓冲液(PBS)存在下进行。
- 对照评估琥珀酸对18F-氟胆碱摄取和滞留的影响,并进行葡萄糖转运蛋白1(GLUT1)免疫组化以评估18F-FDG摄取与GLUT1染色的相关性。
主要发现
- 瘤内注射琥珀酸显著增加小动物PET/CT显像和放射自显影中24小时的18F-FDG摄取。
- 体外对癌细胞未观察到琥珀酸效应,但发现琥珀酸以浓度依赖方式增加人脐静脉内皮细胞的18F-FDG摄取。
- 瘤内注射富马酸或PBS后未观察到显著效应。
- 琥珀酸、富马酸和PBS对细胞活力无影响,与细胞谱系无关。
- 与PBS或富马酸相比,肌内注射琥珀酸也显著增加肌肉的18F-FDG摄取,突出琥珀酸对结缔组织的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
In recent years, inherited and acquired mutations in the tricarboxylic acid (TCA) cycle enzymes have been reported in diverse cancers. Pheochromocytomas and paragangliomas often exhibit dysregulation of glucose metabolism, which is also driven by mutations in genes encoding the TCA cycle enzymes or by activation of hypoxia signaling. Pheochromocytomas and paragangliomas associated with succinate dehydrogenase (SDH) deficiency are characterized by high 18F-FDG avidity. This association is currently only partially explained. Therefore, we hypothesized that accumulation of succinate due to the TCA cycle defect could be the major connecting hub between SDH-mutated tumors and the 18F-FDG uptake profile. Methods: To test whether succinate modifies the 18F-FDG metabolic profile of tumors, we performed in vitro and in vivo (small-animal PET/CT imaging and autoradiography) experiments in the presence of succinate, fumarate, and phosphate-buffered saline (PBS) in different cell models. As a control, we also evaluated the impact of succinate on 18F-fluorocholine uptake and retention. Glucose transporter 1 (GLUT1) immunohistochemistry was performed to assess whether 18F-FDG uptake correlates with GLUT1 staining. Results: Intratumoral injection of succinate significantly increased 18F-FDG uptake at 24 h on small-animal PET/CT imaging and autoradiography. No effect of succinate was observed on cancer cells in vitro, but interestingly, we found that succinate caused increased 18F-FDG uptake by human umbilical vein endothelial cells in a concentration-dependent manner. No significant effect was observed after intratumoral injection of fumarate or PBS. Succinate, fumarate, and PBS have no effect on cell viability, regardless of cell lineage. Intramuscular injection of succinate also significantly increases 18F-FDG uptake by muscle when compared with either PBS or fumarate, highlighting the effect of succinate on connective tissues. No difference was observed between PBS and succinate on 18F-fluorocholine uptake in the tumor and muscle and on hind limb blood flow. GLUT1 expression quantification did not significantly differ between the study groups. Conclusion: The present study shows that succinate stimulates 18F-FDG uptake by endothelial cells, a finding that partially explains the 18F-FDG metabotype observed in tumors with SDH deficiency. Although this study is an 18F-FDG-based approach, it provides an impetus to better characterize the determinants of 18F-FDG uptake in various tumors and their surrounding microenvironment, with a special emphasis on the role of tumor-specific oncometabolites.
引用
- Garrigue P, Bodin-Hullin A, Balasse L, et al. The Evolving Role of Succinate in Tumor Metabolism: An 18F-FDG-Based Study. J Nucl Med. 2017. PMID: 28619735. doi:10.2967/jnumed.117.192674
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。